Articles with public access mandates - Marta ScorsettiLearn more
Not available anywhere: 2
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia
JYC Wong, AR Filippi, M Scorsetti, S Hui, LP Muren, P Mancosu
The Lancet Oncology 21 (10), e477-e487, 2020
Mandates: US National Institutes of Health
Applications of artificial intelligence in stereotactic body radiation therapy
P Mancosu, N Lambri, I Castiglioni, D Dei, M Iori, D Loiacono, S Russo, ...
Physics in Medicine & Biology 67 (16), 16TR01, 2022
Mandates: Government of Italy
Available somewhere: 20
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer …
M Guckenberger, Y Lievens, AB Bouma, L Collette, A Dekker, MS Nandita, ...
The Lancet Oncology 21 (1), e18-e28, 2020
Mandates: Cancer Research UK
Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography
M Infante, S Cavuto, FR Lutman, E Passera, M Chiarenza, G Chiesa, ...
American journal of respiratory and critical care medicine 191 (10), 1166-1175, 2015
Mandates: Fondazione Cariplo
Preservation of axillary lymph nodes compared with complete dissection in T1–2 breast cancer patients presenting one or two metastatic sentinel lymph nodes: the SINODAR-ONE …
C Tinterri, D Gentile, W Gatzemeier, A Sagona, E Barbieri, A Testori, ...
Annals of surgical oncology 29 (9), 5732-5744, 2022
Mandates: Government of Italy
PEACE V–Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): A study protocol for a randomized controlled phase II trial
A De Bruycker, A Spiessens, P Dirix, N Koutsouvelis, I Semac, ...
BMC cancer 20, 1-12, 2020
Mandates: Research Foundation (Flanders)
Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease
L Toschi, G Finocchiaro, TT Nguyen, MC Skokan, L Giordano, ...
PloS one 9 (4), e95303, 2014
Mandates: US National Institutes of Health
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
T Zilli, V Achard, A Dal Pra, N Schmidt-Hegemann, BA Jereczek-Fossa, ...
Radiotherapy and Oncology 176, 199-207, 2022
Mandates: US National Institutes of Health, Cancer Research UK, National Institute for …
Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19
LT Tchelebi, K Haustermans, M Scorsetti, A Hosni, F Huguet, MA Hawkins, ...
Radiotherapy and Oncology 148, 194-200, 2020
Mandates: National Institute for Health Research, UK
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective
A Barry, S Apisarnthanarax, GM O'Kane, G Sapisochin, R Beecroft, ...
The Lancet Gastroenterology & Hepatology 5 (8), 765-775, 2020
Mandates: National Institute for Health Research, UK
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus
BA Jereczek-Fossa, G Marvaso, M Zaffaroni, SG Gugliandolo, D Zerini, ...
Cancer treatment reviews 98, 102206, 2021
Mandates: National Institute for Health Research, UK, Government of Italy
Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines
M Yan, AV Louie, R Kotecha, MA Ahmed, Z Zhang, M Guckenberger, ...
Lung Cancer 182, 107281, 2023
Mandates: Cancer Research UK, National Institute for Health Research, UK
Stereotactic body radiation therapy for hepatocellular carcinoma: meta-analysis and International Stereotactic Radiosurgery Society Practice Guidelines
SH Bae, SJ Chun, JH Chung, E Kim, JK Kang, WI Jang, JE Moon, ...
International Journal of Radiation Oncology* Biology* Physics 118 (2), 337-351, 2024
Mandates: Cancer Research UK, National Institute for Health Research, UK
Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient‐level data from 4 prospective trials
HK Perlow, RN Prasad, M Yang, B Klamer, J Matsui, L Marrazzo, B Detti, ...
Cancer 128 (12), 2367-2374, 2022
Mandates: US National Institutes of Health
Gantry-mounted linear accelerator–based stereotactic body radiation therapy for low-and intermediate-risk prostate cancer
AT Dang, RG Levin-Epstein, D Shabsovich, M Cao, C King, FI Chu, ...
Advances in Radiation Oncology 5 (3), 404-411, 2020
Mandates: US National Institutes of Health
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results
G Francolini, M Ganovelli, V Di Cataldo, B Detti, S Caini, M Loi, ...
Clinical & experimental metastasis 40 (2), 197-201, 2023
Mandates: US National Institutes of Health
Internal guidelines for reducing lymph node contour variability in total marrow and lymph node irradiation
D Dei, N Lambri, S Stefanini, V Vernier, RC Brioso, L Crespi, E Clerici, ...
Cancers 15 (5), 1536, 2023
Mandates: Government of Italy
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2
BA Jereczek-Fossa, M Pepa, G Marvaso, JL Isaksson, CP Soatti, ...
Medical Oncology 37, 1-9, 2020
Mandates: Government of Italy
A bibliometric analysis of the Oligometastatic state over the last two decades: a shifting Paradigm for oncology? an AIRO Oligometastatic study group
G Marvaso, F Mastroleo, G Corrao, M Zaffaroni, MG Vincini, P Borghetti, ...
Cancers 15 (15), 3902, 2023
Mandates: AIRC Foundation for Cancer Research in Italy
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study
BA Jereczek-Fossa, MF Palazzi, S Tonoli, M Zaffaroni, G Marvaso, ...
Tumori Journal 108 (2), 177-181, 2022
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program